Showing results (91-100 of 117) with videos related to
Sort By:
Pageof 12
Journal of Affective Disorders|May 24, 2022
Cross-cultural validity of the WHO-5 Well-Being Index and Euthymia Scale: A clinimetric analysisDanilo Carrozzino, Kaj Sparle Christensen, Chiara Patierno, et al.Medicine|February 9, 2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case reportElisa Giannetta, Andrea M Isidori, Cosimo Durante, et al.Oncoimmunology|September 14, 2016
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancerEleonora Timperi, Ilenia Pacella, Valeria Schinzari, et al.Journal of Cancer Research and Clinical Oncology|February 20, 2017
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE studyMaria Rita Migliorino, Antonio Santo, Giampiero Romano, et al.Clinical Lung Cancer|May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutationsGabriella Farina, Flavia Longo, Olga Martelli, et al.Oncotarget|September 30, 2015
KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapyMirko Marabese, Monica Ganzinelli, Marina C Garassino, et al.The Lancet. Oncology|July 26, 2013
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trialMarina Chiara Garassino, Olga Martelli, Massimo Broggini, et al.Clinical Breast Cancer|December 3, 2014
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian surveyNicola Tinari, Caterina Fanizza, Marilena Romero, et al.Scientific Reports|November 18, 2015
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)Monica Ganzinelli, Eliana Rulli, Elisa Caiola, et al.Schizophrenia Research|April 19, 2017
The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disordersGiovanni Mansueto, Martine van Nierop, Koen Schruers, et al.Pageof 12